Recent Publication
Muntasir Alam, Takeo Kuwata, Kazuya Shimura, Masaru Yokoyama, Kristel Paola Ramirez Valdez,
Kazuki Tanaka, Yasuhiro Maruta Shinya Oishi, Nobutaka Fujii, Hironori Sato, Masao Matsuoka
and Shuzo Matsushita: Enhanced antibody‑mediated neutralization of HIV‑1 variants that are resistant to fusion inhibitors.
Retrovirology (2016) 13:70Miyazaki N, Sugiura W, Gatanaga H, Watanabe D., Yamamoto Y., Yokomaku Y., Yoshimura K., Matsushita S , the Japanese HIV-MDR Study Group. High antiretroviral coverage and viral suppression prevalence in Japan: an excellent profile for downstream HIV care spectrum. Jpn. J. Infect. Dis., June 30, 2016
Shuzo Matsushita, Kazuhisa Yoshimura, Kristel Paola Ramirez, Jaya Pisupati, Toshio Murakami, the KD-1002 Study Group. Passive transfer of neutralizing mAb KD-247 reduces plasma viral load in patients chronically infected with HIV-1. AIDS, 29(4), 453-462, 2015.
Kristel Paola Ramirez Valdez, Takeo Kuwata, Yasuhiro Maruta, Kazuki Tanaka, Muntasir Alam, Kazuhisa Yoshimura, Shuzo Matsushita. Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains. Virology, 475, 187-203, 2015.
Kirby, K.A., Ong Y.T., Hachiya, A., Laughlin, T.G., Chiang, L.A., Pan, Y., Moran, J.L., Marchand, B., Singh, K., Gallazzi, F., Quinn, T.P., Yoshimura, K., Murakami, T., Matsushita, S., Sarafianos, S.G.. Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247. The FASEB Journal, 29(1), 70-80, 2015.